Dr Reddy#39;s drops 4% after being named in US anti-trust lawsuit

The complaint accuses Dr Reddy#39;s of improperly restraining competition and maintaining a monopoly in the sale of the cancer drug Revlimid

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *